Ryman asks for director fee increase to almost $1 million
The last time shareholders voted for an increase was 2014.
Calida Smylie Fri, 24 Jun 2016
Ryman Healthcare [NZX:RYM] is seeking shareholder approval to get directors’ fees increased to $910,000.
In its notice of annual meeting and annual report, both released this morning, the listed retirement village operator informs shareholders it is calling a vote on the proposal at the annual
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).